quantisnow
FeedTopReportsPricing
⌘K
Live feed
09:00:00·738d
PRRelease
Frequency Therapeutics Inc. logo
UroGen Pharma Ltd. logo
Voyager Therapeutics Inc. logo
+1

NorthStar Appoints Peter Pfreundschuh to Board of Managers

FREQ· Frequency Therapeutics Inc.URGN· UroGen Pharma Ltd.VYGR· Voyager Therapeutics Inc.IMMU· Immunomedics, Inc.
Health Care
Original source

Companies

  • FREQ
    Frequency Therapeutics Inc.
    Health Care
  • URGN
    UroGen Pharma Ltd.
    Health Care
  • VYGR
    Voyager Therapeutics Inc.
    Health Care
  • IMMU
    Immunomedics, Inc.
    Health Care

Recent analyst ratings

  • Apr 10URGNUpdateJefferies$40.00
  • Aug 19URGNUpdatePiper Sandler$36.00
  • Jun 16URGNUpdateH.C. Wainwright$50.00
  • May 22URGNUpdateH.C. Wainwright-
  • Apr 16URGNUpdateScotiabank$23.00
  • Feb 19URGNUpdateLadenburg Thalmann$31.00

Related

  • SEC2d
    Voyager Therapeutics Inc. filed SEC Form 8-K: Leadership Update
  • SEC6d
    SEC Form PRE 14A filed by UroGen Pharma Ltd.
  • SEC13d
    SEC Form PRE 14A filed by Voyager Therapeutics Inc.
  • ANALYST13d
    Jefferies initiated coverage on UroGen Pharma with a new price target
  • PR15d
    UroGen Launches LG-UTUC Luminaries Initiative Recognizing Excellence and Leadership in Treatment of Patients with Low-Grade Upper Tract Urothelial Cancer
  • INSIDER20d
    SEC Form 4 filed by Sandrock Alfred
  • INSIDER20d
    SEC Form 4 filed by Shiferman Gregory L.
  • SEC21d
    SEC Form 144 filed by Voyager Therapeutics Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022